Diagnosis at the first episode to differentiate antidepressant treatment responses in patients with mood and anxiety disorders

Psychopharmacology

Volumn 160, Issue 1, 2002, Pages 67-73

  De Kemp, E ^a,b,c,d,e,f   Moleman, P ^a,b,c,d,e,f   Hoogduin, C ^a,b,c,d,e,f   Broekman, T ^a,b,c,d,e,f   Goedhart, A ^a,b,c,d,e,f   Schaap, C ^a,b,c,d,e,f   Van den Berg, P ^a,b,c,d,e,f  

^a University of Nijmegen ^*  (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Moleman Research BV   (Netherlands)

^d Bureau Bêta Nijmegen   (Netherlands)

^e University of Groningen ^*  (Netherlands)

^f UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Affective disorder; Anxiety; Depression; Pharmacotreatment; Primary diagnosis

Indexed keywords

ALPRAZOLAM; DIAZEPAM; FLUVOXAMINE; IMIPRAMINE; LORMETAZEPAM; OXAZEPAM;

ADULT; AGED; ANXIETY NEUROSIS; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY DISORDERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUVOXAMINE; HUMANS; IMIPRAMINE; MALE; MIDDLE AGED; MOOD DISORDERS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0036179520     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-001-0947-4     Document Type: Article

References (39)

1. Contemporary management of depression
2. Recall of depressive episode 25 years previously
3. A comprehensive psychopathological rating scale
4. A comparison of fluvoxamine, cognitive therapy and placebo in the treatment of panic disorder
5. A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients
6. Short-term treatment of mood disorders with standard antidepressants
7. The empirical structure of psychiatric comorbidity and its theoretical significance
8. Anxiety syndromes as epiphenomena of primary major depression: Outcome and familial psychopathology
9. Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; A double blind comparative study with fluvoxamine and maprotiline
10. Analysis of longitudinal data beyond MANOVA
11. Development of diagnostic checklists for use in routine clinical care. A guideline designed to assess DSM-III-R diagnoses
12. Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety
13. Prevalence, correlates, and course of minor depression and major depression in the national comorbidity survey
14. Reanalysis of the National Institute of Mental Health treatment of depression collaborative research program general effectiveness report
15. Paroxetine - A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study
16. A comparison of symptom determinants of patient and clinical global ratings in patients with panic disorder and depression
17. Imipramine treatment of panic disorder with agoraphobia: Dose ranging and plasma level-response relationships
18. Clomipramine - An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder
19. A new depression scale designed to be sensitive to change
20. Measurement of change in psychiatric illness: New obsessional, schizophrenia and depression scales
21. Pharmacological treatment of obsessive-compulsive disorder
22. Fluoxetine versus phenelzine in atypical depression
23. The pharmacological treatment of depression
24. Antidepressants for the treatment of generalized anxiety disorder - A placebo-controlled comparison of imipramine, trazodone, and diazepam
25. Paroxetine efficacy in the treatment of generalized anxiety disorder
26. Selective serotonin reuptake inhibitors - Meta-analysis of efficacy and acceptability
27. A new self-rating scale for depression and anxiety states based on the comprehensive psychopathological rating scale
28. Social phobia: A review of pharmacological treatment
29. Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial
30. The brief scale for anxiety: A subdivision of the comprehensive psychopathological rating scale
31. A meta-analysis of the treatment of panic disorder with or without agoraphobia: A comparison of psychopharmacological, cognitive- behavioral, and combination treatments
32. Meta-analysis of double blind placebo controlled trials of antidepressants and benzodiazepines for patients with panic disorders
33. All roads lead to depression: Clinically homogeneous, etiologically heterogeneous